Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharm Block 1 > 6 - Pharmacogenetics > Flashcards

6 - Pharmacogenetics Flashcards

1
Q

What is the current empirical strategy for drug therapy? What is the problem with this?

A

Treat all patients with the same diagnosis with the same mediation at the same starting dose.

Problem: some people will respond, some will be nonresponders (which can be an ADR if the condition is serious), and some will have toxicity (ADR).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are pharmacogenetics?

A

Genetic factors that alter an individuals response to a drug.

Based on genetic polymorphisms and less common genetic variants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a genotype? What is a phenotype?

A

Genotype: individuals composition at the gene level, ie the specific genes they have determined by their DNA sequenece.

Phenotype: individuals expression of their genotype; the observable physical or biochem characteristics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a genetic polymorphism?

A

Mendelian trait that exists in the population in at least two phenotypes, neither of which is rare.
-At least one variant needs to represent greater than 1% of the total pool (of the population).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a single nucleotide polymorphism (SNP)? Do these always have a consequence?

A

A change in one single base pair in the DNA sequence that differs from the wild type or predominant sequence.

May or may not result in a phenotype.

> 99% have no phenotypic influence and don’t influence expression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

In many cases ____ SNPS influence the phenotype. How do we categorize these?

A

Multiple SNPs.

We call this a haplotype: closely liked SNPs present on one chromosome that tend to be inherited together within a gene or closely linked genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a halotype? How does this differ from a haplotype?

A

A cluster of SNPs that occur together in an individual.

Could be in a single gene (like a haplotype) or could be in distant genes or chromosomes (not a haplotype).

Most commonly studied halotypes are in closely linked SNPs, making them also haplotypes (so just say haplotypes).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is autosomal co-dominance? What does autosomal recessive mean? Autosomal dominant?

A

Co-dominance: each allele contributes to a a phenotype.

Recessive: wild-type allele has predominant effect; takes two alleles to see the effect

Dominant: single allele predominates other the others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is homozygous? What is heterozygous?

A

Homozygous: having two identical alleles (AA, aa)

Heterozygous: having two different alleles (Aa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the things that pharmacokinetics impact?

A

Transporters, plasma protein binding, metabolism, excretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are things that pharmacodynamics impact?

A

Receptors, ion channels, enzymes, and signaling events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the NAT-2 polymorphism associated with?

A

Increased neurological side effects in pts receiving drug ISONIAZID.

N-acetyltransferase 2 detoxifies isoniazid and polymorphisms in NAT-2 explain fast vs slow acetylators.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe slow and fast acetylators of isoniazid in the context of NAT2 polymorphisms?

A

Slow acetylators are homozygous for the slow allele and break down the drug more slowly (drug stays in body longer)

Fast acetylators have 1 or two copies of the fast allele.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a CYP2D6 polymorphism associated with?

A

DEBRISOQUINE effect:

  • Excessive hypotension
  • correlated with increased debrisoquine concentrations and decreased debrisoquine metabolism

(this drug used to treat high blood pressure)

CYP2D6 polymorphisms liked to poor metabolizers - drug stays in body longer and has a more severe effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How common are CYP2D6 variant alleles? What do they account for in the population?

A

There’s over 75 variant alleles, 7 of which account for more than 90% of the poor metabolizers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the CYP2D6 poor metabolizer phenotypic frequency (2 copies of slow alleles) overall? What does this mean?

A

2-10% of patients will be poor metabolizers.

Poor metabolizers will have increased side effects because they can’t metabolize the drug fast enough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the overall prevalence of CYP2D6 ultrafast metabolizers? What is this caused by? What does this mean?

A

1-30% of patients will be ultrafast metabolizers.

This means that they have a large number of copies of the normal allele.

Means they degrade the drug too quickly and don’t get a benefit from it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is an important drug type that’s metabolized by CYP2D6?

A

Antidepressants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What percent of the population has the CYP2C19 polymorphism and are homozygous poor metabolizers? This effects the metabolism of which drugs?

A

3-20%.

Omeprazole: poton pump inhibitor

Phenytoin: anti-convulsant

Clopidogrel: anti-platelet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How can being a poor metabolizer with a CYP2C19 polymorphism be a benefit?

A

Poor metabolizers using Omeprazole have higher drug levels, which correlate with increased gastric pH and higher cure rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the function of Clopidogrel and how is it affected by CYP2C19? What results from having a slow allele?

A

It inhibits platelet aggregation following an MI.

Activated by CYP2C19.

Those with even one slow allele (34% of pop) have a 53% increase in serious cardiovascular outcomes.

22
Q

What is dangerous about giving patients (even those who are normal metabolizers) clopidogrel post-MI and omeprazole to limit gastric irritation (from aspirin) at the same time?

A

Omeprazole and clopidogrel are both CYP2D6 substrates and competitive inhibition will occur, resulting in clopidogrel not being activated.

Higher rate of MI and death in patients getting both.

23
Q

What are two low activity alleles associated with the CYP2C9 slow metabolizer polymorphism?

What percentage of patients have the first and/or second low activity allele?

A

CYP2C92 and CYP2C3 are low activity alleles

Together *2 and/or *3 alleles are in up to 31% of the patients.

24
Q

What is an example of a drug impacted by CYP2C9 polymorphisms?

A

Warfarin: anticoagulant

25
Q

What occurs when blood levels of warfarin are too high? What about when blood levels are too low?

A

Too high: serious bleeding events

Too low: intravascular clotting including stroke

26
Q

How is warfarin cleared from the body? What impact do polymorphisms have?

A

Almost exclusively by CYP2C9.

CYP2C9*2 and *3 significantly reduce warfarin clearance and increase the half life.
-require lower maintenance dose and have increase rick of bleeding

27
Q

What is VKORC1? what effect does warfarin have on it?

A

A vitamin K receptor - a subunit of the vitamin K epoxide reductase complex.

Warfarin is a vitamin K antagonist and competitively inhibits the activity of VKORC1.

28
Q

What is the function of VKORC1?

A

Converts clotting factors to the mature form when they are needed.

When it’s inhibited (by warfarin) you can’t clot effectively).

29
Q

What haplotpes of VKORC1 require low warfarin doses? What about the haplotypes that require high warfarin doses? What clade is each associated with?

A

Require low doses: H1 and H1 - clade A

Require high dose: H7. H8. H9 - clade B

30
Q

What clade of VKORC1 is common in asian-americans? What about african americans or people of european descent

A

Asian americans: A clade

African americans: B clade

European descent: Mix of A and B

31
Q

Does VKORC1 effect half life?

A

NO.

32
Q

Are there ultrafast variants of CYP2C9?

A

NO.

33
Q

How do the actions of CYP2C9 and VKORC1 differ?

A

CYP2C9 inactivates warfarin

VKORC1 is a competitive inhibitor of warfarin.

34
Q

How should you dose a person with CYP2C9*2 or *3 alleles for warfarin?

A

They have a longer warfarin half life because they can’t metabolize the drug as fast.

They need lower doses.

35
Q

What is a pseudocholinesterase polymorphism? What does it cause?

A

A variant response to SUCCINYLCHOLINE, a surgical skeletal muscle relaxant which effects usually last 5 min after dose stopped.

Atypical pts experience apnea and paralysis for 2-3 hrs.

May increase susceptibility to some insecticides and cocaine toxicity.

36
Q

Is there only one pseudocholinesterase polymorphism? What is the incidence?

A

No, there’s multiple reduced activity variants of pseudocholinesterase.

1-6% of the population.

37
Q

What is a TPMT polymorphism associated with? Spell out the drug this is related to. What is TPMT?

A

TPMT is thiopurine methyltransferase

An increased risk for life-threatening bone marrow suppression in cancer pts treated with 6-MERCAPTOPURINE.

38
Q

What is the action of TPMT?

A

It methylates 6-mercaptopurine to inactivate it.

39
Q

What is the frequency/risk of one or two low activity alleles of TPMT? What is the associated outcome of each?

A

11% of the population has one abnormal allele - elevated risk of bone marrow suppression from 6-MP

0.3% of the pop has two abnormal alleles - high risk of bone marrow suppression from 6-MP

DNA testing is recommended by the FDA.

40
Q

What is SLCO1B1 (OATP1B1)?

A

An organic anion transported important for the uptake of some hydrophilic drugs in the liver.

41
Q

What drugs are widely used for decreasing cholesterol? What is their action? What is the most concerning side effect?

A

Statins - competitively inhibit HMG-coA reductase (rate limiting step of cholesterol biosyn).

Skeletal muscle toxicity.

42
Q

What do low activity polymorphisms of SLCO1B1 lead to? What is the risk of this?

A

Elevated blood levels of some statins such as SIMVASTATIN (less so for atorvastatin).

Elevated simvastatin levels are associated with increased risk of myopathy.

43
Q

What is the risk of having one “C” low expression allele of SLCO1B1? What about 2? What does this mean for dosage?

A

One C allele: partial uptake into the liver; increased myopathy risk – consider lower dose or different statin

Two C alleles: further decreased in uptake into the liver; further increased myopathy risk – lower dose, CK monitoring, or try another statin.

44
Q

Other drugs that interact with OATP1B1 have the potential to do what?

A

Affect statin levels/toxicity and could have even greater impact on pts with low activity alleles of SLCO1B1

45
Q

Polymorphisms have a greater significance for what type of drugs?

A

Drugs with a relatively narrow therapeutic window.

The narrower the window, the more people that will fall outside of that window with a polymorphism.

46
Q

Tylenol with codeine was given for post-operative pain and a child died. What did they likely die from and what caused this? What is the genetic basis for this?

A

Excessive morphine levels caused by CYP2D6 ultrafast metabolizers.

This is because CYP2D6 activates codeine to morphine.

Ultrafast metabolizers have multiple copies (up to 13) of the normal CYP2D6 allele.

47
Q

Both ____ polymorphisms and ______ expression effect the dosage of warfarin that your patient needs.

A

CYP2C9 - warfarin clearance

VKORC1 expression - blocked by warfarin

48
Q

What does 6-mercaptopurine normally do?

A

Inhibits purine synthesis and causes nucleotides to be mis-incorporated into DNA and RNA.

49
Q

What polymorphism affects receptors or enzyme targets?

A

VKORC1

50
Q

What polymorphisms affect drug absorption/uptake?

A

SLC01B1

51
Q

What happens when a patient is given Tylenol with codeine? What does this mean for poor metabolizers and fast metabolizers?

A

CYP2D6 converts some of the codeine to morphine.

Poor metabolizers will not convert much codeine to morphine and have little pain relief.

High metabolizers will convert too much to morphine and have toxic effects.

Pharm Block 1 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions